These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8522471)

  • 1. Assay of vancomycin by fluorescence polarisation immunoassay and EMIT in patients with renal failure.
    Saunders NJ; Want SV; Adams DJ
    J Antimicrob Chemother; 1995 Aug; 36(2):411-5. PubMed ID: 8522471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Falsely elevated serum vancomycin concentrations in hemodialysis patients.
    Follin SL; Mueller BA; Scott MK; Carfagna MA; Kraus MA
    Am J Kidney Dis; 1996 Jan; 27(1):67-74. PubMed ID: 8546140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin serum concentrations in patients with renal dysfunction: a comparison of fluorescence polarization immunoassay and the enzyme-multiplied immunoassay technique.
    Peckman HJ; Dupuis RE; Sawyer WT; Brouwer KL; Cross RE
    Ther Drug Monit; 1996 Dec; 18(6):647-53. PubMed ID: 8946660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF; Petros WP; Soucie MP; Copeland KR
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin assay performance in patients with acute renal failure.
    Trujillo TN; Sowinski KM; Venezia RA; Scott MK; Mueller BA
    Intensive Care Med; 1999 Nov; 25(11):1291-6. PubMed ID: 10654216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instability of standard calibrators may be involved in overestimating vancomycin concentrations determined by fluorescence polarization immunoassay.
    Morishige H; Shuto H; Ieiri I; Otsubo K; Oishi R
    Ther Drug Monit; 1996 Feb; 18(1):80-5. PubMed ID: 8848826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence polarization immunoassay: can it result in an overestimation of vancomycin in patients not suffering from renal failure?
    Sym D; Smith C; Meenan G; Lehrer M
    Ther Drug Monit; 2001 Aug; 23(4):441-4. PubMed ID: 11477330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference with vancomycin fluorescence polarisation immunoassay in a nonuraemic patient.
    Bowhay S; Timms P
    Ther Drug Monit; 1997 Feb; 19(1):117-9. PubMed ID: 9029761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin assay performance in patients with end-stage renal disease receiving hemodialysis.
    Kingery JR; Sowinski KM; Kraus MA; Klaunig JE; Mueller BA
    Pharmacotherapy; 2000 Jun; 20(6):653-6. PubMed ID: 10853620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Emit tox benzodiazepine and barbiturate assays on the Vitalab Viva analyser and FPIA on the Abbott ADx analyser.
    Charlier CJ; Plomteux GJ
    Clin Chem Lab Med; 2000 Jul; 38(7):615-8. PubMed ID: 11028766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring, of heart transplant recipients.
    Regazzi MB; Molinaro M; Tinelli C; D'Eril GM; Goggi C; Campana C; Fiorito V; Moratti R; Viganò M
    Ther Drug Monit; 2000 Dec; 22(6):712-5. PubMed ID: 11128239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of vancomycin in renally impaired patient samples using a new high-performance liquid chromatography method with vitamin B12 internal standard: comparison of high-performance liquid chromatography, emit, and fluorescence polarization immunoassay methods.
    Hu MW; Anne L; Forni T; Gottwald K
    Ther Drug Monit; 1990 Nov; 12(6):562-9. PubMed ID: 2275003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of vancomycin serum concentrations in patients with renal failure.
    Perino LM; Mueller BA
    Ann Pharmacother; 1993; 27(7-8):892-3. PubMed ID: 8364273
    [No Abstract]   [Full Text] [Related]  

  • 14. More information on vancomycin clearance by new hemodialysis membranes.
    Mueller BA; Scott MK; Clark WR
    Am J Health Syst Pharm; 1996 Jun; 53(11):1339-40, 1348. PubMed ID: 8725212
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of high-performance liquid chromatography with fluorescence polarization immunoassay for the analysis of vancomycin in patients with chronic renal failure.
    Najjar TA; al-Dhuwailie AA; Tekle A
    J Chromatogr B Biomed Appl; 1995 Oct; 672(2):295-9. PubMed ID: 8581137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overestimation of serum vancomycin concentrations using a fluorescence polarization immunoassay (Tdx) in preterm neonates.
    Paap CM; Sharpe GL
    Dev Pharmacol Ther; 1993; 20(3-4):174-9. PubMed ID: 7828450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential problem with fluorescence polarization immunoassay cross-reactivity to vancomycin degradation product CDP-1: its detection in sera of renally impaired patients.
    Anne L; Hu M; Chan K; Colin L; Gottwald K
    Ther Drug Monit; 1989 Sep; 11(5):585-91. PubMed ID: 2683253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underestimation of rat serum vancomycin concentrations measured by an enzyme-multiplied immunoassay technique and the strategy for its avoidance.
    Konishi H; Iga I; Nagai K
    Drug Test Anal; 2014 Apr; 6(4):350-6. PubMed ID: 23943307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of bioassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for quantitative determination of vancomycin in serum.
    Ristuccia PA; Ristuccia AM; Bidanset JH; Cunha BA
    Ther Drug Monit; 1984; 6(2):238-42. PubMed ID: 6377600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of the EMIT-tox benzodiazepine immunoassay, FPIA serum benzodiazepine immunoassay, and radioreceptor assay in suspected acute poisoning.
    Verstraete AG; Belpaire FM; Leroux-Roels GG
    J Anal Toxicol; 1998; 22(1):27-32. PubMed ID: 9491965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.